The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Achilles Therapeutics; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene; Celgene; EQRx; Immutep; Janssen Oncology; Lilly; Merck Serono; Merck Sharp & Dohme; Oxford VacMedix; Pfizer; PharmaMar; Roche; Takeda; Transgene; UltraHuman
Research Funding - Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Achilles Therapeutics; AstraZeneca; Bristol-Myers Squibb; Celgene; Immutep; Janssen Oncology; MSD Oncology; Roche
Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (DEP CTX) in patients with advanced solid cancers in a phase 1/2 trial (P1/2).
 
James F. Spicer
Stock and Other Ownership Interests - Epsilogen
Consulting or Advisory Role - Apobec Discovery (Inst); AstraZeneca (Inst); Avacta Life Sciences (Inst); Roche (Inst)
Research Funding - Achilles Therapeutics (Inst); BerGenBio (Inst); BluPrint Oncology (Inst); Bristol-Myers Squibb (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); IO Biotech (Inst); Roche (Inst); RS Oncology (Inst); Starpharma (Inst); Trizell (Inst)
Patents, Royalties, Other Intellectual Property - Use of IgE antibodies for treatment of cancer
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Janssen
 
David James Pinato
Honoraria - Avammune; Bristol-Myers Squibb; Da Volterra; Lift Biosciences; Mursla Bio; Roche/Genentech; Starpharma
Consulting or Advisory Role - AstraZeneca; Da Volterra; EISAI; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley
 
Martin Forster
No Relationships to Disclose
 
Anthony M. Joshua
Stock and Other Ownership Interests - Opthea; Pricilium Therapeutics
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Grey Wolf Therapeutics (Inst); IDEAYA Biosciences (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Medison (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Starpharma (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Cancer therapeutic methods
 
James Korolewicz
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - Boehlringer Ingelheim
 
Karam Aboud
No Relationships to Disclose
 
Cienne Morton
Honoraria - MSD
Travel, Accommodations, Expenses - SERVIER
 
Jia (Jenny) Liu
Honoraria - MSD; Specialised Therapeutics
Consulting or Advisory Role - Greywolf Therapeutics (Inst); Starpharma (Inst)
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - ImmVirX; MSD; Starpharma
 
Rasha Cosman
No Relationships to Disclose
 
Nicola Jane Main
Employment - Starpharma
Stock and Other Ownership Interests - Starpharma
 
Julia Le Meur
Employment - Starpharma
 
Jeremy Paull
Employment - Starpharma
Leadership - Starpharma
Stock and Other Ownership Interests - Starpharma
Patents, Royalties, Other Intellectual Property - Patents for dendrimer technology generated as part of employment, owned by Starpharma.
 
Stephanie Ruth Edmondson
Employment - Starpharma
Stock and Other Ownership Interests - Starpharma
Research Funding - Starpharma
Patents, Royalties, Other Intellectual Property - Starpharma
Travel, Accommodations, Expenses - Starpharma
 
Robert Hugh Jones
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - SERVIER; Starpharma